Vanguard Group
EVFM

Vanguard Group’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,304,514
Closed -$1.47M 4663
2022
Q2
$1.47M Sell
1,304,514
-5,114,731
-80% -$5.78M ﹤0.01% 3945
2022
Q1
$2.18M Sell
6,419,245
-441,721
-6% -$150K ﹤0.01% 3920
2021
Q4
$2.58M Sell
6,860,966
-148,892
-2% -$55.9K ﹤0.01% 3947
2021
Q3
$5.18M Hold
7,009,858
﹤0.01% 3635
2021
Q2
$7.92M Buy
7,009,858
+2,845,077
+68% +$3.21M ﹤0.01% 3331
2021
Q1
$7.29M Buy
4,164,781
+568,292
+16% +$994K ﹤0.01% 3333
2020
Q4
$8.67M Buy
3,596,489
+126,973
+4% +$306K ﹤0.01% 3065
2020
Q3
$8.19M Buy
3,469,516
+928,113
+37% +$2.19M ﹤0.01% 2883
2020
Q2
$7.19M Buy
2,541,403
+1,917,483
+307% +$5.43M ﹤0.01% 2918
2020
Q1
$3.32M Buy
623,920
+209,308
+50% +$1.11M ﹤0.01% 3150
2019
Q4
$2.56M Sell
414,612
-3,196
-0.8% -$19.7K ﹤0.01% 3376
2019
Q3
$2.11M Sell
417,808
-240,283
-37% -$1.21M ﹤0.01% 3433
2019
Q2
$4.37M Buy
658,091
+354,408
+117% +$2.35M ﹤0.01% 3215
2019
Q1
$1.06M Buy
303,683
+29,246
+11% +$102K ﹤0.01% 3614
2018
Q4
$1.15M Buy
274,437
+57,391
+26% +$240K ﹤0.01% 3528
2018
Q3
$879K Buy
+217,046
New +$879K ﹤0.01% 3749
2018
Q1
Sell
-1,820
Closed -$4K 4106
2017
Q4
$4K Sell
1,820
-118,254
-98% -$260K ﹤0.01% 4059
2017
Q3
$55K Sell
120,074
-28,281
-19% -$13K ﹤0.01% 4025
2017
Q2
$80K Buy
148,355
+43,528
+42% +$23.5K ﹤0.01% 4001
2017
Q1
$168K Buy
104,827
+32,130
+44% +$51.5K ﹤0.01% 3932
2016
Q4
$81K Sell
72,697
-900
-1% -$1K ﹤0.01% 3992
2016
Q3
$82K Buy
73,597
+12,410
+20% +$13.8K ﹤0.01% 3998
2016
Q2
$60K Hold
61,187
﹤0.01% 4070
2016
Q1
$37K Sell
61,187
-121,719
-67% -$73.6K ﹤0.01% 4097
2015
Q4
$255K Buy
182,906
+69,956
+62% +$97.5K ﹤0.01% 3977
2015
Q3
$912K Buy
112,950
+36,096
+47% +$291K ﹤0.01% 3658
2015
Q2
$691K Buy
76,854
+26,754
+53% +$241K ﹤0.01% 3771
2015
Q1
$411K Buy
50,100
+100
+0.2% +$820 ﹤0.01% 3878
2014
Q4
$374K Buy
+50,000
New +$374K ﹤0.01% 3803